Scientists test new drug duo in fight against advanced cancers
NCT ID NCT01582191
Summary
This early-stage trial tested a combination of two oral drugs, vandetanib and everolimus, in people with advanced cancer that had spread or stopped responding to standard treatments. The main goals were to find the safest dose of the drug pair and to check for side effects. Researchers also wanted to see if the combination showed any early signs of helping to control cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.